1. Home
  2. NTRA vs FITB Comparison

NTRA vs FITB Comparison

Compare NTRA & FITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$272.94

Market Cap

56.7B

Sector

Health Care

ML Signal

N/A

Logo Fifth Third Bancorp

FITB

Fifth Third Bancorp

N/A

Current Price

$49.39

Market Cap

47.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NTRA
FITB
Founded
2003
1858
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
56.7B
47.0B
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
NTRA
FITB
Price
$272.94
$49.39
Analyst Decision
Strong Buy
Buy
Analyst Count
23
22
Target Price
★ $412.36
$61.54
AVG Volume (30 Days)
2.0M
★ 5.3M
Earning Date
11-05-2026
10-19-2026
Dividend Yield
N/A
★ 3.30%
EPS Growth
0.65
★ 12.42
EPS
N/A
★ 1.94
Revenue
$210,939,000.00
★ $577,000,000.00
Revenue This Year
$30.72
$42.26
Revenue Next Year
$21.67
$9.46
P/E Ratio
★ N/A
$26.21
Revenue Growth
N/A
★ N/A
52 Week Low
$181.00
$41.87
52 Week High
$437.41
$59.50

Technical Indicators

Market Signals
Indicator
NTRA
FITB
Relative Strength Index (RSI) 24.66 32.32
Support Level $254.83 $48.83
Resistance Level $288.04 $51.20
Average True Range (ATR) 19.03 1.39
MACD -7.70 -0.49
Stochastic Oscillator 1.47 2.92

Price Performance

Historical Comparison
NTRA
FITB

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About FITB Fifth Third Bancorp

Fifth Third Bancorp is a midsize regional bank in the US, with total assets of around $300 billion as of September 2026. The bank closed its acquisition of Comercia in February 2026. Headquartered in Cincinnati, Ohio, Fifth Third has a strong presence in the US Midwest and is currently expanding in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and Treasury management, wealth and asset management, and capital markets.

Share on Social Networks: